🗓️ IPO Timeline & Structure
-
IPO Open: June 9–11, 2025
-
Price Band: ₹96–102 per share (FV ₹10)
-
Lot Size: 1,200 shares (~₹1.15 – 1.22 L)
-
Issue Size: ₹61.62 crore via fresh issue of 6.04 lakh shares on NSE SME
-
Allotment: Promise date June 12; Listing expected June 16, 2025
💰 What They’ll Do With the Funds
-
₹56.5 Cr (91%) for a new manufacturing + R&D facility in Gautam Budh Nagar, UP
-
Remainder for corporate purposes
📈 Subscription & GMP Highlights
🔹 Day 1 Response:
-
Overall subscription: ~2.35×
-
Retail investors: ~3.7× uptake
-
Institutional appetite: mild
-
GMP: ₹30 (30% premium)
🔹 Day 2 Surge:
-
Total bids ~16–21× oversubscribed by midday
-
Retail: 20–24×; NIIs: ~28–42×; QIBs: ~4–8.5×
-
GMP stable near ₹30; implies
29–32% listing jump (₹132 pop)
🧪 What They Make & Why It Matters
Sacheerome, founded in 1992, specializes in fragrances and flavours for sectors like personal care, home care, food & beverage, exported to Middle East, Africa, and beyond
-
R&D strength: 45+ professionals, proprietary tech & labs
-
Global-ready model: India’s own “taste & scent” co‑creation platform positions it well against multinationals
-
Financials: FY25 revenue ₹107 Cr, net profit ₹16 Cr (growth ~50%), EBITDA margin ~21.6%
📝 IPO Reviews & Analyst Commentary
-
Ariyah Capital – “Neutral” rating, citing R&D and recurring B2B orders; valuations at upper band fair (~P/E 14× on FY25 EPS ₹7.14)
-
InvestorZone highlights management pedigree: Chair Manoj Arora, 40 years in industry; strong export capabilities
-
-
📌 Sacheerome IPO GMP Snapshot
Date GMP (₹) Estimated Listing Price Premium Over ₹102 Day 1 30 ~132 ~29.5% Day 2 (Till Noon) 30–32 ~132–134 ~29–32%
✅ Should You Subscribe?
Pros:
-
Backed by strong retail momentum
-
Robust grey-market premium, indicating high listing probability
-
Solid R&D capabilities, diverse exports, and growing profitability
Cons / Risks:
-
SME IPOs typically exhibit higher listing volatility
-
Limited institutional participation
-
Dependence on IPO proceeds for capacity expansion
🌟 Final Verdict
Sacheerome’s robust subscription, healthy GMP, and quality fundamentals make it a promising SME IPO pick. Buying at the upper band (~₹102) could yield 25–30% listing gains if momentum holds. ₹
Disclaimer:
I am not a SEBI-registered investment adviser. All the content shared on this blog is for informational and educational purposes only. Please consult a SEBI-registered financial advisor before making any investment decisions. -
